- Previous Close
1.7300 - Open
1.6800 - Bid 1.7400 x --
- Ask 1.7600 x --
- Day's Range
1.6800 - 1.8100 - 52 Week Range
1.6000 - 5.2000 - Volume
4,178 - Avg. Volume
12,075 - Market Cap (intraday)
41.085M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.10
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden. The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
chemotech.seRecent News: CMOTEC-B.ST
View MorePerformance Overview: CMOTEC-B.ST
Trailing total returns as of 11/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CMOTEC-B.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CMOTEC-B.ST
View MoreValuation Measures
Market Cap
40.39M
Enterprise Value
39.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.03
Price/Book (mrq)
4.50
Enterprise Value/Revenue
7.84
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-59.07%
Return on Equity (ttm)
-197.97%
Revenue (ttm)
5.16M
Net Income Avi to Common (ttm)
-15.7M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.58M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-12.44M